Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California.
Department of Obstetrics, University of Ulm, Ulm, Germany.
JAMA. 2019 Nov 19;322(19):1877-1886. doi: 10.1001/jama.2019.16004.
Umbilical cord milking as an alternative to delayed umbilical cord clamping may provide equivalent benefits to preterm infants, but without delaying resuscitation.
To determine whether the rates of death or severe intraventricular hemorrhage differ among preterm infants receiving placental transfusion with umbilical cord milking vs delayed umbilical cord clamping.
DESIGN, SETTING, AND PARTICIPANTS: Noninferiority randomized clinical trial of preterm infants (born at 23-31 weeks' gestation) from 9 university and private medical centers in 4 countries were recruited and enrolled between June 2017 and September 2018. Planned enrollment was 750 per group. However, a safety signal comprising an imbalance in the number of severe intraventricular hemorrhage events by study group was observed at the first interim analysis; enrollment was stopped based on recommendations from the data and safety monitoring board. The planned noninferiority analysis could not be conducted and a post hoc comparison was performed instead. Final date of follow-up was December 2018.
Participants were randomized to umbilical cord milking (n = 236) or delayed umbilical cord clamping (n = 238).
The primary outcome was a composite of death or severe intraventricular hemorrhage to determine noninferiority of umbilical cord milking with a 1% noninferiority margin.
Among 540 infants randomized, 474 (88%) were enrolled and completed the trial (mean gestational age of 28 weeks; 46% female). Twelve percent (29/236) of the umbilical cord milking group died or developed severe intraventricular hemorrhage compared with 8% (20/238) of the delayed umbilical cord clamping group (risk difference, 4% [95% CI, -2% to 9%]; P = .16). Although there was no statistically significant difference in death, severe intraventricular hemorrhage was statistically significantly higher in the umbilical cord milking group than in the delayed umbilical cord clamping group (8% [20/236] vs 3% [8/238], respectively; risk difference, 5% [95% CI, 1% to 9%]; P = .02). The test for interaction between gestational age strata and treatment group was significant for severe intraventricular hemorrhage only (P = .003); among infants born at 23 to 27 weeks' gestation, severe intraventricular hemorrhage was statistically significantly higher with umbilical cord milking than with delayed umbilical cord clamping (22% [20/93] vs 6% [5/89], respectively; risk difference, 16% [95% CI, 6% to 26%]; P = .002).
In this post hoc analysis of a prematurely terminated randomized clinical trial of umbilical cord milking vs delayed umbilical cord clamping among preterm infants born at less than 32 weeks' gestation, there was no statistically significant difference in the rate of a composite outcome of death or severe intraventricular hemorrhage, but there was a statistically significantly higher rate of severe intraventricular hemorrhage in the umbilical cord milking group. The early study termination and resulting post hoc nature of the analyses preclude definitive conclusions.
ClinicalTrials.gov Identifier: NCT03019367.
与延迟脐带结扎相比,脐带挤奶作为一种替代方法,可能为早产儿提供同等的益处,但不会延迟复苏。
确定接受胎盘输血的早产儿与延迟脐带结扎相比,接受脐带挤奶的死亡率或严重脑室内出血的发生率是否不同。
设计、地点和参与者:这是一项非劣效性随机临床试验,研究对象为来自 4 个国家的 9 家大学和私人医疗中心的 23-31 周龄早产儿。研究于 2017 年 6 月至 2018 年 9 月间招募并纳入了参与者。计划每组纳入 750 名参与者。然而,第一次中期分析时观察到研究组严重脑室内出血事件数量的不平衡存在安全性信号;根据数据和安全监测委员会的建议,停止了入组。计划的非劣效性分析无法进行,因此进行了事后比较。最终随访日期为 2018 年 12 月。
参与者被随机分配到脐带挤奶组(n = 236)或延迟脐带结扎组(n = 238)。
主要结局是死亡或严重脑室内出血的复合结局,以确定脐带挤奶的非劣效性,非劣效性边界为 1%。
在随机分配的 540 名婴儿中,有 474 名(88%)被纳入并完成了试验(平均胎龄 28 周;46%为女性)。脐带挤奶组中有 12%(29/236)的婴儿死亡或发生严重脑室内出血,而延迟脐带结扎组中有 8%(20/238)(风险差异,4%[95%CI,-2%至 9%];P = .16)。尽管死亡率没有统计学上的显著差异,但脐带挤奶组的严重脑室内出血发生率明显高于延迟脐带结扎组(分别为 8%[236 例]和 3%[238 例];风险差异,5%[95%CI,1%至 9%];P = .02)。仅在严重脑室内出血方面,治疗组间的交互检验具有统计学意义(P = .003);在胎龄 23 至 27 周的婴儿中,与延迟脐带结扎相比,脐带挤奶的严重脑室内出血发生率明显更高(分别为 22%[93 例]和 6%[89 例];风险差异,16%[95%CI,6%至 26%];P = .002)。
在这项提前终止的早产儿出生时胎龄小于 32 周的脐带挤奶与延迟脐带结扎的随机临床试验的事后分析中,死亡或严重脑室内出血的复合结局发生率没有统计学上的显著差异,但脐带挤奶组的严重脑室内出血发生率明显更高。研究的早期终止和由此产生的事后分析性质排除了明确的结论。
ClinicalTrials.gov 标识符:NCT03019367。